Comments
Loading...
Évaluations des analystes, objectifs de prix, prévision
Lear Corp a un objectif de cours consensus de $133.95, basé sur les évaluations des 20 analystes. Le plus élevé est de $200 attribué par Benchmark le janvier 2, 2024, et le plus bas est de $84 attribué par Goldman Sachs le avril 10, 2025. Les 3 dernières évaluations d'analystes ont été publiées par UBS, Barclays et UBS le juillet 28, 2025, juillet 16, 2025 et juillet 14, 2025. Avec un objectif de cours moyen de $115 entre UBS, Barclays et UBS, il y a une variation implicite de 11.44% upside pour Lear Corp à partir de ces dernières évaluations d'analystes.
Sociétés d'analyse émettant des recommandations1
UBS
Barclays
Wells Fargo
Citigroup
B of A Securities
1calculé à partir des notes des analystes
Notes d'analystes pour Lear
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
07/28/2025 | 5.63% | UBS | $116 → $109 | Maintains | Neutral | |||
07/16/2025 | 16.29% | Barclays | $100 → $120 | Maintains | Equal-Weight | |||
07/14/2025 | 12.41% | UBS | $95 → $116 | Maintains | Neutral | |||
07/01/2025 | -0.18% | Wells Fargo | $100 → $103 | Maintains | Equal-Weight | |||
06/30/2025 | 31.8% | Citigroup | $123 → $136 | Maintains | Buy | |||
06/16/2025 | 11.44% | B of A Securities | $110 → $115 | Maintains | Buy | |||
05/19/2025 | 11.44% | Morgan Stanley | $125 → $115 | Maintains | Overweight | |||
05/19/2025 | -3.09% | Wells Fargo | $89 → $100 | Maintains | Equal-Weight | |||
05/09/2025 | 16.29% | JP Morgan | $119 → $120 | Maintains | Overweight | |||
05/07/2025 | -7.94% | UBS | $83 → $95 | Maintains | Neutral | |||
05/07/2025 | -13.75% | Wells Fargo | $87 → $89 | Maintains | Equal-Weight | |||
04/23/2025 | 19.2% | Citigroup | → $123 | Initiates | → Buy | |||
04/22/2025 | 6.6% | B of A Securities | $135 → $110 | Maintains | Buy | |||
04/15/2025 | -17.63% | Barclays | $115 → $85 | Maintains | Equal-Weight | |||
04/10/2025 | -19.57% | UBS | $102 → $83 | Maintains | Neutral | |||
04/10/2025 | -18.6% | Goldman Sachs | $117 → $84 | Downgrade | Buy → Neutral | |||
03/03/2025 | 21.14% | Morgan Stanley | $135 → $125 | Maintains | Overweight | |||
02/10/2025 | 6.6% | Evercore ISI Group | $125 → $110 | Maintains | In-Line | |||
02/07/2025 | -1.15% | UBS | $104 → $102 | Maintains | Neutral | |||
02/07/2025 | -0.18% | Wells Fargo | $99 → $103 | Maintains | Equal-Weight | |||
01/27/2025 | 38.58% | JP Morgan | $147 → $143 | Maintains | Overweight | |||
01/22/2025 | 11.44% | Barclays | $120 → $115 | Maintains | Equal-Weight | |||
01/16/2025 | 0.78% | UBS | $107 → $104 | Maintains | Neutral | |||
12/16/2024 | -4.06% | Wells Fargo | $106 → $99 | Maintains | Equal-Weight | |||
11/14/2024 | 30.83% | Morgan Stanley | $145 → $135 | Maintains | Overweight | |||
10/30/2024 | 16.29% | Barclays | $140 → $120 | Downgrade | Overweight → Equal-Weight | |||
10/25/2024 | 3.69% | UBS | $119 → $107 | Maintains | Neutral | |||
10/25/2024 | 21.14% | TD Cowen | $142 → $125 | Maintains | Buy | |||
10/25/2024 | 2.72% | Wells Fargo | $114 → $106 | Maintains | Equal-Weight | |||
10/21/2024 | 55.05% | JP Morgan | $162 → $160 | Maintains | Overweight | |||
10/15/2024 | 35.67% | Barclays | $150 → $140 | Maintains | Overweight | |||
10/14/2024 | 64.74% | B of A Securities | $180 → $170 | Maintains | Buy | |||
10/04/2024 | 15.32% | UBS | $128 → $119 | Maintains | Neutral | |||
10/01/2024 | 30.83% | Goldman Sachs | $144 → $135 | Maintains | Buy | |||
09/25/2024 | 40.52% | Morgan Stanley | $150 → $145 | Maintains | Overweight | |||
09/20/2024 | 10.48% | Wells Fargo | $131 → $114 | Maintains | Equal-Weight | |||
09/10/2024 | 27.92% | Deutsche Bank | → $132 | Reinstates | → Hold | |||
08/14/2024 | 45.36% | Morgan Stanley | $160 → $150 | Maintains | Overweight | |||
07/29/2024 | 45.36% | Barclays | $155 → $150 | Maintains | Overweight | |||
07/26/2024 | 26.95% | Wells Fargo | $132 → $131 | Maintains | Equal-Weight | |||
07/22/2024 | 79.28% | B of A Securities | $205 → $185 | Maintains | Buy | |||
07/22/2024 | 60.87% | JP Morgan | $179 → $166 | Maintains | Overweight | |||
07/16/2024 | 50.21% | Barclays | $165 → $155 | Maintains | Overweight | |||
07/15/2024 | 40.52% | Evercore ISI Group | $155 → $145 | Maintains | In-Line | |||
07/12/2024 | 23.07% | Citigroup | $141 → $127 | Maintains | Neutral | |||
07/10/2024 | 24.04% | UBS | $136 → $128 | Maintains | Neutral | |||
06/25/2024 | 27.92% | Wells Fargo | $139 → $132 | Maintains | Equal-Weight | |||
06/13/2024 | 31.8% | UBS | $142 → $136 | Maintains | Neutral | |||
05/10/2024 | 55.05% | Morgan Stanley | $150 → $160 | Upgrade | Equal-Weight → Overweight | |||
05/02/2024 | 59.9% | Barclays | $175 → $165 | Maintains | Overweight | |||
05/01/2024 | 36.64% | Citigroup | $145 → $141 | Maintains | Neutral | |||
05/01/2024 | 34.7% | Wells Fargo | $134 → $139 | Maintains | Equal-Weight | |||
05/01/2024 | 37.61% | UBS | $146 → $142 | Maintains | Neutral | |||
04/22/2024 | 73.47% | JP Morgan | $177 → $179 | Maintains | Overweight | |||
04/11/2024 | 69.59% | Barclays | $170 → $175 | Maintains | Overweight | |||
02/26/2024 | 45.36% | Morgan Stanley | $140 → $150 | Maintains | Equal-Weight | |||
02/07/2024 | 29.86% | Wells Fargo | $130 → $134 | Maintains | Equal-Weight | |||
01/25/2024 | 73.47% | JP Morgan | $195 → $179 | Maintains | Overweight | |||
01/24/2024 | 64.74% | Barclays | $175 → $170 | Maintains | Overweight | |||
01/02/2024 | 93.82% | Benchmark | $188 → $200 | Maintains | Buy | |||
10/30/2023 | 82.19% | Benchmark | → $188 | Reiterates | Buy → Buy | |||
10/30/2023 | 69.59% | Barclays | $177 → $175 | Maintains | Overweight | |||
10/12/2023 | — | Barclays | — | Upgrade | Equal-Weight → Overweight | |||
10/11/2023 | 47.3% | Citigroup | $158 → $152 | Maintains | Neutral | |||
10/10/2023 | 40.52% | UBS | $150 → $145 | Maintains | Neutral | |||
10/03/2023 | 37.61% | Wells Fargo | $164 → $142 | Maintains | Equal-Weight | |||
09/13/2023 | 45.36% | UBS | → $150 | Initiates | → Neutral | |||
08/07/2023 | 82.19% | Benchmark | $182 → $188 | Maintains | Buy | |||
08/02/2023 | 74.44% | Argus Research | $150 → $180 | Maintains | Buy | |||
08/02/2023 | 76.37% | Benchmark | $170 → $182 | Maintains | Buy | |||
08/02/2023 | 53.12% | Citigroup | $152 → $158 | Maintains | Neutral | |||
08/02/2023 | 58.93% | Wells Fargo | $144 → $164 | Maintains | Equal-Weight | |||
07/20/2023 | 73.47% | JP Morgan | $169 → $179 | Maintains | Overweight | |||
07/18/2023 | 47.3% | Citigroup | $140 → $152 | Maintains | Neutral | |||
07/11/2023 | 59.9% | Barclays | $150 → $165 | Maintains | Equal-Weight | |||
07/10/2023 | 39.55% | Wells Fargo | $141 → $144 | Maintains | Equal-Weight | |||
06/28/2023 | 42.46% | Deutsche Bank | $137 → $147 | Maintains | Hold | |||
06/28/2023 | 76.37% | Benchmark | $170 → $182 | Maintains | Buy | |||
06/28/2023 | 35.67% | Morgan Stanley | $135 → $140 | Maintains | Equal-Weight | |||
06/01/2023 | — | Exane BNP Paribas | — | Upgrade | Neutral → Outperform | |||
05/01/2023 | 35.67% | Citigroup | $143 → $140 | Maintains | Neutral | |||
05/01/2023 | 45.36% | Barclays | $155 → $150 | Maintains | Equal-Weight | |||
04/28/2023 | 32.76% | Deutsche Bank | $136 → $137 | Maintains | Hold | |||
04/28/2023 | 28.89% | Wells Fargo | $141 → $133 | Maintains | Equal-Weight | |||
04/10/2023 | 36.64% | Wells Fargo | $146 → $141 | Maintains | Equal-Weight | |||
03/22/2023 | 30.83% | Morgan Stanley | $133 → $135 | Maintains | Equal-Weight | |||
02/07/2023 | 38.58% | Citigroup | $146 → $143 | Maintains | Neutral | |||
02/06/2023 | 40.52% | Evercore ISI Group | $150 → $145 | Downgrade | Outperform → In-Line | |||
02/03/2023 | 67.65% | Cowen & Co. | $165 → $173 | Maintains | Outperform | |||
02/03/2023 | 64.74% | Benchmark | → $170 | Reiterates | → Buy | |||
01/20/2023 | 64.74% | Benchmark | $162 → $170 | Maintains | Buy | |||
01/17/2023 | 35.67% | Wells Fargo | $139 → $140 | Maintains | Equal-Weight | |||
01/13/2023 | 41.49% | Citigroup | $138 → $146 | Maintains | Neutral | |||
12/14/2022 | 34.7% | Wells Fargo | $149 → $139 | Downgrade | Overweight → Equal-Weight | |||
11/02/2022 | 44.39% | Wells Fargo | $157 → $149 | Maintains | Overweight | |||
11/02/2022 | 33.73% | Citigroup | $137 → $138 | Maintains | Neutral | |||
11/02/2022 | 32.76% | RBC Capital | $142 → $137 | Maintains | Sector Perform | |||
11/02/2022 | 28.89% | Morgan Stanley | $140 → $133 | Maintains | Equal-Weight | |||
09/29/2022 | 37.61% | RBC Capital | $158 → $142 | Maintains | Sector Perform | |||
09/28/2022 | 32.76% | Citigroup | $162 → $137 | Maintains | Neutral |
FAQ
Quel est le cours indicatif de l'action Lear (LEA) ?
Le dernier objectif de prix pour Lear (NYSE:LEA) a été rapporté par UBS le juillet 28, 2025. Le cabinet d'analystes a fixé un objectif de prix pour $109.00 s'attendant à ce que LEA se rise dans les 12 prochains mois (un possible changement de 6.30% upside). 37 cabinets d'analystes ont rapporté des notes au cours de la dernière année.
Quelle est la note d'analyste la plus récente pour Lear (LEA) ?
La dernière note d'analyste pour Lear (NYSE:LEA) a été fournie par UBS, et Lear maintenu leur note neutral.
Quand a eu lieu la dernière mise à niveau pour Lear (LEA) ?
La dernière amélioration pour Lear Corp a eu lieu le mai 10, 2024 lorsque Morgan Stanley a augmenté leur objectif de prix à $160. Morgan Stanley avait précédemment an equal-weight pour Lear Corp.
Quand a eu lieu la dernière dégradation pour Lear (LEA) ?
La dernière réduction pour Lear Corp a eu lieu le avril 10, 2025 lorsque Goldman Sachs a changé leur objectif de prix de $117 à $84 pour Lear Corp.
Quand la prochaine note d'analyste sera-t-elle publiée ou mise à jour pour Lear (LEA) ?
Les analystes arrivent à des évaluations d'actions après avoir effectué des recherches approfondies, ce qui inclut l'examen des états financiers publics, la discussion avec les dirigeants et les clients de Lear, et l'écoute des conférences téléphoniques sur les résultats. La plupart des analystes font cela tous les trois mois, vous devriez donc obtenir 4 notes par entreprise par société chaque année. La dernière note pour Lear a été déposée le juillet 28, 2025, donc vous devriez vous attendre à ce que la prochaine note soit disponible vers juillet 28, 2026.
La note d'analyste pour Lear (LEA) est-elle correcte ?
Bien que les évaluations soient subjectives et changeront, la dernière note de Lear (LEA) était un maintenu avec un objectif de prix de $116.00 à $109.00. Le prix actuel de Lear (LEA) est de $102.54, ce qui est out of la fourchette prédite par l'analyste.
Parcourir notes d'analystes et objectifs de cours sur toutes les actions.